AU678858B2 - Controlled release potassium dosage form - Google Patents

Controlled release potassium dosage form Download PDF

Info

Publication number
AU678858B2
AU678858B2 AU78757/94A AU7875794A AU678858B2 AU 678858 B2 AU678858 B2 AU 678858B2 AU 78757/94 A AU78757/94 A AU 78757/94A AU 7875794 A AU7875794 A AU 7875794A AU 678858 B2 AU678858 B2 AU 678858B2
Authority
AU
Australia
Prior art keywords
dosage unit
micropellets
unit according
coating
ethylcellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU78757/94A
Other languages
English (en)
Other versions
AU7875794A (en
Inventor
Chih-Ming Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Andrx Pharmaceuticals LLC
Original Assignee
Andrx Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrx Pharmaceuticals LLC filed Critical Andrx Pharmaceuticals LLC
Publication of AU7875794A publication Critical patent/AU7875794A/en
Assigned to ANDRX PHARMACEUTICALS, INC. reassignment ANDRX PHARMACEUTICALS, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: CHEN, CHIH-MING
Application granted granted Critical
Publication of AU678858B2 publication Critical patent/AU678858B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AU78757/94A 1993-10-04 1994-09-23 Controlled release potassium dosage form Ceased AU678858B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/131,118 US5397574A (en) 1993-10-04 1993-10-04 Controlled release potassium dosage form
US131118 1993-10-04
PCT/US1994/010580 WO1995009617A1 (en) 1993-10-04 1994-09-23 Controlled release potassium dosage form

Publications (2)

Publication Number Publication Date
AU7875794A AU7875794A (en) 1995-05-01
AU678858B2 true AU678858B2 (en) 1997-06-12

Family

ID=22447956

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78757/94A Ceased AU678858B2 (en) 1993-10-04 1994-09-23 Controlled release potassium dosage form

Country Status (9)

Country Link
US (1) US5397574A (OSRAM)
EP (1) EP0804172B1 (OSRAM)
JP (1) JPH09510430A (OSRAM)
AT (1) ATE211649T1 (OSRAM)
AU (1) AU678858B2 (OSRAM)
CA (1) CA2172624A1 (OSRAM)
DE (1) DE69429632T2 (OSRAM)
NZ (1) NZ274646A (OSRAM)
WO (1) WO1995009617A1 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
HU221435B (en) * 1998-02-20 2002-10-28 Egyt Gyogyszervegyeszeti Gyar Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production
CA2394588A1 (en) * 1999-12-16 2001-06-21 Melissa Gantt Controlled release kcl tablet formulations
WO2002094173A2 (en) * 2001-05-22 2002-11-28 Euro-Celtique Tamper resistant oral dosage form
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
CA2447984A1 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Dosage forms having an inner core and outer shell with different shapes
US6780437B2 (en) * 2001-10-23 2004-08-24 Upsher-Smith Laboratories, Inc. Coated potassium chloride granules and tablets
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US6635675B2 (en) 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
CA2479350A1 (en) * 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
US20040156844A1 (en) * 2002-05-22 2004-08-12 Curtis Wright Tamper resistant oral dosage form
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
JP2006515008A (ja) * 2003-01-28 2006-05-18 コレギウム ファーマシューティカル， インコーポレイテッド 経口投与のためのミルナシプランの多粒子状組成物
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
WO2007059372A2 (en) * 2005-11-09 2007-05-24 St. Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
US8124598B2 (en) * 2006-09-14 2012-02-28 Sharon Sageman 7-keto DHEA for psychiatric use
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use
US20090181094A1 (en) * 2008-01-15 2009-07-16 Eric Yueh-Lang Sheu Molecular Cage for Sustained Release Control of Pharmaceutical and Cosmetic Agents
AU2009279372A1 (en) 2008-08-06 2010-02-11 Gosforth Centre (Holdings) Pty Ltd Compositions and methods for treating psychiatric disorders
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
WO2015073736A1 (en) 2013-11-13 2015-05-21 Arbor Pharmaceuticals, Llc Methods and compositions for treating adhd
US20180362974A1 (en) 2015-07-02 2018-12-20 University Of Louisville Research Foundation, Inc. EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798724A (en) * 1985-06-24 1989-01-17 Ciba-Geigy Corporation Solid, stable dosage forms with an elastic film coating

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL241476A (OSRAM) * 1958-07-24
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
IT1191050B (it) * 1982-10-27 1988-02-24 Pietro Tommaso Tessitore 2(1-alchil-5-nitro)-imidazolil-1-(2-idrossi-5-alchil)-fenil-carbinoli,loro metodo di preparazione e composizioni farmaceutiche che li contengono
JPS61151109A (ja) * 1984-12-26 1986-07-09 Lion Corp 毛髪化粧料組成物
JPS61171413A (ja) * 1985-01-17 1986-08-02 Pola Chem Ind Inc 養毛料
US4863743A (en) * 1985-02-19 1989-09-05 Key Pharmaceuticals, Inc. Controlled release potassium chloride
IE59066B1 (en) * 1985-02-19 1993-12-15 Key Pharma Controlled release potassium chloride
JPS62175417A (ja) * 1986-01-27 1987-08-01 Kanebo Ltd 養毛化粧料
JPS6396106A (ja) * 1986-10-11 1988-04-27 Shiseido Co Ltd 化粧料
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
IE60383B1 (en) * 1988-05-27 1994-07-13 Elan Corp Plc Controlled release pharmaceutical formulation
JPH02111710A (ja) * 1988-10-20 1990-04-24 Akio Fujikawa 化粧料組成物
JPH03206021A (ja) * 1990-01-08 1991-09-09 Kanebo Ltd 養毛化粧料
JP2969866B2 (ja) * 1990-08-29 1999-11-02 大正製薬株式会社 発毛剤
JPH04308523A (ja) * 1991-04-04 1992-10-30 Kanebo Ltd 養毛化粧料
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798724A (en) * 1985-06-24 1989-01-17 Ciba-Geigy Corporation Solid, stable dosage forms with an elastic film coating

Also Published As

Publication number Publication date
DE69429632D1 (de) 2002-02-14
DE69429632T2 (de) 2002-11-14
EP0804172A4 (OSRAM) 1997-11-05
EP0804172B1 (en) 2002-01-09
CA2172624A1 (en) 1995-04-13
AU7875794A (en) 1995-05-01
US5397574A (en) 1995-03-14
JPH09510430A (ja) 1997-10-21
ATE211649T1 (de) 2002-01-15
NZ274646A (en) 1997-02-24
WO1995009617A1 (en) 1995-04-13
EP0804172A1 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
EP0804172B1 (en) Controlled release potassium dosage form
AU676229B2 (en) Stable extended release oral dosage composition
US4424235A (en) Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
CA1318602C (en) Controlled release combination of carbidopa/levodopa
US7374781B2 (en) Sustained release formulations containing acetaminophen and tramadol
CA2163433C (en) Multiparticulate pulsatile drug delivery system
RU2236847C2 (ru) Композиции в виде множества частиц с модифицированным высвобождением
CN1119993C (zh) 醋氨酚、假麻黄碱、扑尔敏和可有可无的美沙芬的旋转制粒及包衣
RU2001111887A (ru) Композиция в виде множества частиц с модифицированным высвобождением
ZA200209525B (en) Oral Pharmaceutical composition with controlled release and prolonged absorption.
JPH0753365A (ja) γ−ヒドロキシ酪酸塩による制御放出能をもつ薬化学組成物
JPS6116368B2 (OSRAM)
KR20030013460A (ko) 치료제의 위 체류 및 방출 조절을 위한 급속 팽창성조성물과 이 조성물을 포함하는 제형
JP2006528976A (ja) 減少された乱用潜在性を有する薬物製剤
JPS62501845A (ja) 制御放出塩化カリウム
US5589190A (en) Sustained-release compositions of alfuzosin hydrochloride
BR112020008128A2 (pt) comprimidos de liberação retardada de deferiprona e métodos para utilização dos mesmos
CA2606740A1 (en) Quinine-containing controlled-release formulations
EP1109535B1 (en) Extended release acetaminophen
KR20080041669A (ko) 매일 단일 투여량 형태로 투여하기에 적합한 구안파신의약학적 제형물/조성물
Radhika et al. Formulation and Evaluation of Sustained Release Matrix Tablets of Glipizide: Sustained release matrix tablets of glipizide
JP3170855B2 (ja) イブプロフェン含有解熱鎮痛剤
US4863743A (en) Controlled release potassium chloride
JPH08239327A (ja) 慢性骨格筋疼痛の予防又は治療剤
EP0121901A1 (en) pH independent controlled releasable tablets